J Buxbaum, G Gallo - Hematology/oncology clinics of North America, 1999 - Elsevier
B-cell proliferative disorders may display their pathogenic effects by increased cell numbers, increased concentrations of the molecules produced by those cells, or both …
CA Hutchison, P Cockwell, S Stringer… - Journal of the …, 2011 - journals.lww.com
Myeloma kidney is the major cause of severe irreversible renal failure in patients with multiple myeloma. This tubulointerstitial injury is a direct consequence of high …
Département de Néphrologie and Unité INSERM 489, Hôpital Tenon (Assistance Publique- Hôpitaux de Paris) and Université Pierre et Marie Curie, Paris, France alpha-1, 5%; alpha-2 …
N Leung, MA Gertz, SR Zeldenrust, SV Rajkumar… - Kidney international, 2008 - Elsevier
Cast nephropathy is the most common cause of renal disease in multiple myeloma, however, treatment with plasma exchange remains controversial even after 3 randomized …
N Leung, DJ Lager, MA Gertz, K Wilson… - American Journal of …, 2004 - Elsevier
Background: Light-chain deposition disease (LCDD) is a monoclonal gammopathy characterized by nonamyloid deposition of light chain in various organs. A small number of …
GA Herrera, L Joseph, X Gu… - … of pathology & …, 2004 - meridian.allenpress.com
Context.—Renal dysfunction in plasma cell dyscrasias is common. It is the second most common cause of death in patients with myeloma. Objective.—We evaluated 77 sequential …
V Sakhuja, V Jha, S Varma, K Joshi, KL Gupta… - Renal failure, 2000 - Taylor & Francis
Renal involvement in 204 cases with multiple myeloma admitted over a 10-year period to this tertiary care center in north India was retrospectively examined. Renal involvement …
Since the publication of High-Resolution Electrophorsesis and Immunofixation 2e, there have been ever-increasing advances in the analyses of proteins, by electrophoresis in …
P Ronco, E Plaisier, P Aucouturier - Clinical Journal of the …, 2006 - journals.lww.com
Abstract Light-, light-and heavy-, and heavy-chain deposition diseases belong to a family of diseases that include light-chain (AL)-amyloid, nonamyloid fibrillary and immunotactoid …